The DOI matches its Crossref record; 149 of the 149 references it cites were found in a registry or an index.
Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Insulin-Like Growth Factors and Their Binding Proteins: Biological Actions*
JONES, J. I., & CLEMMONS, D. R. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-1-3 · Cited by 4,710
Self-citationLiu, J.-P., Baker, J., Perkins, A. S., Robertson, E. J., & Efstratiadis, A. (1993) · Cell · doi:10.1016/s0092-8674(05)80084-4 · Cited by 2,855
Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study
Chan, J. M., Stampfer, M. J., Giovannucci, E., Gann, P. H., Ma, J., Wilkinson, P., Hennekens, C. H., & Pollak, M. (1998) · Science · doi:10.1126/science.279.5350.563 · Cited by 1,996
Circulating concentrations of insulin-like growth factor I and risk of breast cancer
Hankinson, S. E., Willett, W. C., Colditz, G. A., Hunter, D. J., Michaud, D. S., Deroo, B., Rosner, B., Speizer, F. E., & Pollak, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)10384-1 · Cited by 1,823
DAUGHADAY, W. H., & ROTWEIN, P. (1989) · Endocrine Reviews · doi:10.1210/edrv-10-1-68 · Cited by 1,725
Normal growth and development in the absence of hepatic insulin-like growth factor I
Yakar, S., Liu, J.-L., Stannard, B., Butler, A., Accili, D., Sauer, B., & LeRoith, D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7324 · Cited by 1,420
The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights
Samani, A. A., Yakar, S., LeRoith, D., & Brodt, P. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0001 · Cited by 1,005
Insulin‐like growth factors I and II
HUMBEL, R. E. (1990) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1990.tb15595.x · Cited by 999
Fukuda, R., Hirota, K., Fan, F., Jung, Y. D., Ellis, L. M., & Semenza, G. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203781200 · Cited by 821
Nahta, R., Yuan, L. X. H., Zhang, B., Kobayashi, R., & Esteva, F. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3841 · Cited by 793
Loss of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk
Cui, H., Cruz-Correa, M., Giardiello, F. M., Hutcheon, D. F., Kafonek, D. R., Brandenburg, S., Wu, Y., He, X., Powe, N. R., & Feinberg, A. P. (2003) · Science · doi:10.1126/science.1080902 · Cited by 735
Requirement of p27 Kip1 for Restriction Point Control of the Fibroblast Cell Cycle
Coats, S., Flanagan, W. M., Nourse, J., & Roberts, J. M. (1996) · Science · doi:10.1126/science.272.5263.877 · Cited by 679
Metabolic Syndrome: Connecting and Reconciling Cardiovascular and Diabetes Worlds
Grundy, S. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.11.046 · Cited by 679
Juul, A., Scheike, T., Davidsen, M., Gyllenborg, J., & Jørgensen, T. (2002) · Circulation · doi:10.1161/01.cir.0000027563.44593.cc · Cited by 640
Mitsiades, C. S., Mitsiades, N. S., McMullan, C. J., Poulaki, V., Shringarpure, R., Akiyama, M., Hideshima, T., Chauhan, D., Joseph, M., Libermann, T. A., et al. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00050-9 · Cited by 614
Plasma Levels of Insulin-Like Growth Factor-I and Lung Cancer Risk: a Case-Control Analysis
Yu, H., Spitz, M. R., Mistry, J., Gu, J., Hong, W. K., & Wu, X. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.2.151 · Cited by 554
Garcı́a-Echeverrı́a, C., Pearson, M. A., Marti, A., Meyer, T., Mestan, J., Zimmermann, J., Gao, J., Brueggen, J., Capraro, H.-G., Cozens, R., et al. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00051-0 · Cited by 542
Estrogen Regulation of Growth Hormone Action
Leung, K.-C., Johannsson, G., Leong, G. M., & Ho, K. K. Y. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0035 · Cited by 542
Sell, C., Dumenil, G., Deveaud, C., Miura, M., Coppola, D., DeAngelis, T., Rubin, R., Efstratiadis, A., & Baserga, R. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.6.3604 · Cited by 538
mTOR Complex1–S6K1 signaling: at the crossroads of obesity, diabetes and cancer
Dann, S. G., Selvaraj, A., & Thomas, G. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.04.002 · Cited by 481
Dunn, S. E., Kari, F. W., French, J. E., Leininger, J. R., Travlos, G. S., Wilson, R., & Barrett, J. C. (1997) · PubMed · Cited by 438
Kaleko, M., Rutter, W. J., & Miller, A. D. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.2.464 · Cited by 409
Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis.
Wu, Y., Yakar, S., Zhao, L., Hennighausen, L. G., & LeRoith, D. (2002) · PubMed · Cited by 380
Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes
Fernández, A. M., Kim, J. K., Yakar, S., Dupont, J., Hernandez-Sanchez, C., Castle, A. L., Filmore, J., Shulman, G. I., & Le Roith, D. (2001) · Genes & Development · doi:10.1101/gad.908001 · Cited by 369
Cohen, B. D., Baker, D. A., Soderstrom, C., Tkalcevic, G., Rossi, A. M., Miller, P. E., Tengowski, M. W., Wang, F., Gualberto, A., Beebe, J. S., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1070 · Cited by 365
Lai, E. C., Felice, K. J., Festoff, B. W., Gawel, M. J., Gelinas, D. F., Kratz, R., Murphy, M. F., Natter, H. M., Norris, F. H., Rudnicki, S. A., et al. (1997) · Neurology · doi:10.1212/wnl.49.6.1621 · Cited by 361
A Polymorphism in the Gene for IGF-I
Vaessen, N., Heutink, P., Janssen, J. A., Witteman, J. C. M., Testers, L., Hofman, A., Lamberts, S. W. J., Oostra, B. A., Pols, H. A. P., & van Duijn, C. M. (2001) · Diabetes · doi:10.2337/diabetes.50.3.637 · Cited by 354
Burtrum, D. B., Zhu, Z., Lu, D., Anderson, D. M., Prewett, M. C., PEREIRA, D. S., Bassi, R., Abdullah, R., Hooper, A. T., Koo, H., et al. (2003) · PubMed · Cited by 352
Muscle-specific expression of IGF-1 blocks angiotensin II–induced skeletal muscle wasting
Song, Y., Li, Y., Du, J., Mitch, W. E., Rosenthal, N. A., & Delafontaine, P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522324 · Cited by 348
A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis
Borasio, G. D., Robberecht, W., Leigh, P. N., Emile, J., Guiloff, R. J., Jerusalem, F., Silani, V., Vos, P. E., Wokke, J. H. J., Dobbins, T., et al. (1998) · Neurology · doi:10.1212/wnl.51.2.583 · Cited by 340
Frystyk, J. (2004) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2004.06.001 · Cited by 338
Arteaga, C. L., Kitten, L. J., Coronado, E. B., Jacobs, S., Kull, F. C., Allred, D. C., & Osborne, C. K. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114315 · Cited by 328
The IGF system and breast cancer.
Sachdev, D., & Yee, D. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080197 · Cited by 314
Maloney, E. K., McLaughlin, J. L., Dagdigian, N. E., Garrett, L. M., Connors, K. M., Zhou, X., Blättler, W. A., Chittenden, T. D., & Singh, R. (2003) · PubMed · Cited by 307
IGF1R signalling and its inhibition
Riedemann, J., & Macaulay, V. M. (2006) · Endocrine-Related Cancer · doi:10.1677/erc.1.01280 · Cited by 301
Scotlandi, K., Manara, M. C., Nicoletti, G., Lollini, P.-L., Lukas, S., Benini, S., Croci, S., Perdichizzi, S., Zambelli, D., Serra, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3192 · Cited by 299
Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase
Avruch, J., Hara, K., Lin, Y., Liu, M., Long, X., Ortiz-Vega, S., & Yonezawa, K. (2006) · Oncogene · doi:10.1038/sj.onc.1209882 · Cited by 296
Laviola, L., Natalicchio, A., & Giorgino, F. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207780249146 · Cited by 296
6 Factors controlling blood concentration of somatomedin C
Clemmons, D. R., & Van Wyk, J. J. (1984) · Clinics in Endocrinology and Metabolism · doi:10.1016/s0300-595x(84)80011-0 · Cited by 293
Self-citationMoses, A. C., Young, S. C., Morrow, L. A., O'Brien, M., & Clemmons, D. R. (1996) · Diabetes · doi:10.2337/diab.45.1.91 · Cited by 291
Self-citationGicquel, C., BERTAGNA, X. Y., Gaston, V., Coste, J., Louvel, A., Baudin, É., Bertherat, J. Y., Chapuis, Y., Duclos, J. M., Schlumberger, M. J., et al. (2001) · PubMed · Cited by 285
DiGiovanni, J., Kiguchi, K., Frijhoff, A., Wilker, E., Bol, D. K., Beltrán, L., Moats, S., Ramirez, A., Jorcano, J., & Conti, C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3455 · Cited by 281
Kirstein, M., Aston, C., Hintz, R., & Vlassara, H. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115879 · Cited by 265
BAXTER, R. C. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-5-1347 · Cited by 259
Grinspoon, S. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.11.3864 · Cited by 258
Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1–deficient mice
Yakar, S., Setser, J., Zhao, H., Stannard, B., Haluzik, M., Glatt, V., Bouxsein, M. L., Kopchick, J. J., & LeRoith, D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci17763 · Cited by 252
Expression and distribution of insulin-like growth factor-1 receptor in human carcinomas
Ouban, A., Muraca, P., Yeatman, T., & Coppola, D. (2003) · Human Pathology · doi:10.1016/s0046-8177(03)00291-0 · Cited by 251
Expression of insulin-like growth factor-1 receptor in human colorectal cancer
Hakam, A., Yeatman, T. J., Lu, L., Mora, L., Marcet, G., Nicosia, S. V., Karl, R. C., & Coppola, D. (1999) · Human Pathology · doi:10.1016/s0046-8177(99)90027-8 · Cited by 239
Correction: IGF-IR/HER-2 Contributes to Trastuzumab Resistance
(2008) · Cancer Research · doi:10.1158/0008-5472.can-68-22-cor1 · Cited by 230
BUSBY, W. H., SNYDER, D. K., & CLEMMONS, D. R. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-6-1225 · Cited by 229
Self-citationInsulin-Like Growth Factors in the Fed and Fasted States*
MERIMEE, T. J., ZAPF, J., & FROESCH, E. R. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-5-999 · Cited by 228
Mdm2-dependent ubiquitination and degradation of the insulin-like growth factor 1 receptor
Girnita, L., Girnita, A., & Larsson, O. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1431613100 · Cited by 223
Andrews, D. W., Resnicoff, M., Flanders, A. E., Kenyon, L., Curtis, M., Merli, G., Baserga, R., Iliakis, G., & Aiken, R. D. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.8.2189 · Cited by 222
Liu, T.-J., LaFortune, T., Honda, T., Ohmori, O., Hatakeyama, S., Meyer, T., Jackson, D., de Groot, J., & Yung, W. K. A. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0476 · Cited by 207
Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor
Ish-Shalom, D., Christoffersen, C. T., Vorwerk, P., Sacerdoti-Sierra, N., Shymko, R. M., Naor, D., & Meyts, P. D. (1997) · Diabetologia · doi:10.1007/s001250051393 · Cited by 193
Hartman, M. L., Clayton, P. E., Johnson, M. L., Celniker, A., Perlman, A. J., Alberti, K. G., & Thorner, M. O. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116480 · Cited by 192
Induction of insulin-like growth factor I messenger RNA in rat aorta after balloon denudation.
Cercek, B., Fishbein, M. C., Forrester, J. S., Helfant, R. H., & Fagin, J. A. (1990) · Circulation Research · doi:10.1161/01.res.66.6.1755 · Cited by 191
Gooch, J. L., Van Den Berg, C. L., & Yee, D. (1999) · Breast Cancer Research and Treatment · doi:10.1023/a:1006208721167 · Cited by 191
Sachdev, D., Li, S. L., Hartell, J. S., Fujita‐Yamaguchi, Y., Miller, J. S., & Yee, D. (2003) · PubMed · Cited by 190
Kalebic, T., Tsokos, M., & Helman, L. J. (1994) · PubMed · Cited by 189
Fan, W., Yanase, T., Morinaga, H., Okabe, T., Nomura, M., Daitoku, H., Fukamizu, A., Kato, S., Takayanagi, R., & Nawata, H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610447200 · Cited by 188
Scotlandi, K., Benini, S., Nanni, P., Lollini, P., Nicoletti, G., Landuzzi, L., Serra, M., Manara, M. C., Picci, P., & Baldini, N. (1998) · PubMed · Cited by 185
Warshamana-Greene, G. S., Litz, J., Buchdunger, E., García-Echeverría, C., Hofmann, F., & Krystal, G. W. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1544 · Cited by 184
Lu, D., Zhang, H., Koo, H., Tonra, J., Balderes, P., Prewett, M., Corcoran, E., Mangalampalli, V., Bassi, R., Anselma, D., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500815200 · Cited by 180
Haluska, P., Carboni, J. M., Loegering, D. A., Lee, F. Y., Wittman, M., Saulnier, M. G., Frennesson, D. B., Kalli, K. R., Conover, C. A., Attar, R. M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1107 · Cited by 179
All‐Ericsson, C., Girnita, L., Seregard, S., Bartolazzi, A., Jager, M. J., & Larsson, O. (2002) · PubMed · Cited by 178
Wang, Y., Hailey, J., Williams, D., Wang, Y., Lipari, P., Malkowski, M., Wang, X., Xie, L., Li, G., Saha, D., et al. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0048 · Cited by 171
Wu, J. D., Odman, A., Higgins, L. M., Haugk, K., Vessella, R., Ludwig, D. L., & Plymate, S. R. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1586 · Cited by 167
Overexpression of the insulin‐like growth factor I receptor in human colon carcinomas
Weber, M. M., Fottner, C., Liu, S. B., Jung, M. C., Engelhardt, D., & Baretton, G. B. (2002) · Cancer · doi:10.1002/cncr.10945 · Cited by 164
EDWALL, D., SCHALLING, M., JENNISCHE, E., & NORSTEDT, G. (1989) · Endocrinology · doi:10.1210/endo-124-2-820 · Cited by 164
Putz, T., Čulig, Z., Eder, I. E., Nessler‐Menardi, C., Bartsch, G., Grunicke, H. H., Überall, F., & Klocker, H. (1999) · PubMed · Cited by 158
Trial of Insulinlike Growth Factor I Therapy for Patients With Extreme Insulin Resistance Syndromes
Kuzuya, H., Matsuura∥, N., Sakamoto, M., Makino, H., Sakamoto, Y., Kadowaki, T., Suzuki, Y., Kobayashi, M., Akazawa, Y., Nomura, M., et al. (1993) · Diabetes · doi:10.2337/diab.42.5.696 · Cited by 157
Miyamoto, S., Yano, K., Sugimoto, S., Ishii, G., Hasebe, T., Endoh, Y., Kodama, K., Goya, M., Chiba, T., & Ochiai, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1916 · Cited by 154
Dual Regulation of MMP-2 Expression by the Type 1 Insulin-like Growth Factor Receptor
Zhang, D., Bar‐Eli, M., Meloche, S., & Brodt, P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313145200 · Cited by 152
The Insulin Receptor Isoform Exon 11- (IR-A) in Cancer and Other Diseases: A Review
Denley, A., Wallace, J. C., Cosgrove, L. J., & Forbes, B. E. (2003) · Hormone and Metabolic Research · doi:10.1055/s-2004-814157 · Cited by 150
Zhang, D., & Brodt, P. (2003) · Oncogene · doi:10.1038/sj.onc.1206197 · Cited by 149
Menu, E., Jernberg‐Wiklund, H., Strömberg, T., Raeve, H. D., Girnita, L., Larsson, O., Axelson, M., Asosingh, K., Nilsson, K., Camp, B. V., et al. (2005) · Blood · doi:10.1182/blood-2005-01-0293 · Cited by 145
IGF‐I and microglia/macrophage proliferation in the ischemic mouse brain
O'Donnell, S. L., Frederick, T. J., Krady, J. K., Vannucci, S. J., & Wood, T. L. (2002) · Glia · doi:10.1002/glia.10081 · Cited by 143
Surmacz, E. (2003) · Oncogene · doi:10.1038/sj.onc.1206772 · Cited by 143
Slieker, L. J., Brooke, G. S., DiMarchi, R. D., Flora, D. B., Green, L. K., Hoffmann, J. A., Long, H. B., Fan, L., Shields, J. E., Sundell, K. L., et al. (1997) · Diabetologia · doi:10.1007/s001250051402 · Cited by 138
Zhao, H., Grossman, H. B., Spitz, M. R., Lerner, S. P., ZHANG, K., & Wu, X. (2003) · The Journal of Urology · doi:10.1016/s0022-5347(05)63999-7 · Cited by 138
Wittman, M. D., Carboni, J. M., Attar, R. M., Balasubramanian, B. N., Balimane, P. V., Brassil, P. J., Beaulieu, F., Chang, C. Y., Clarke, W., Dell, J., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050392q · Cited by 137
Chang, Y. S., Wang, L., Liu, D., Mao, L., Hong, W. K., Khuri, F. R., & Lee, H. (2002) · PubMed · Cited by 136
Nakamura, M., Miyamoto, S., Maeda, H., Ishii, G., Hasebe, T., Chiba, T., Asaka, M., & Ochiai, A. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.06.010 · Cited by 135
Manara, M. C., Landuzzi, L., Nanni, P., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1518 · Cited by 134
Martins, A. S., Mackintosh, C., Martín, D. H., Campos, M., Hernández, T., Ordóñez, J. L., & de Álava, E. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1778 · Cited by 133
Mitsui, Y., Mochizuki, S., Kodama, T., Shimoda, M., Ohtsuka, T., Shiomi, T., Chijiiwa, M., Ikeda, T., Kitajima, M., & Okada, Y. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0377 · Cited by 133
Probst-Hensch, N. M., Yuan, J.-M., Stanczyk, F. Z., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2172 · Cited by 127
Lu, D., Zhang, H., Ludwig, D. L., Persaud, A., Jimenez, X., Burtrum, D. B., Balderes, P. J., Liu, M., Böhlen, P., Witte, L., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310132200 · Cited by 124
Bereket, A., Lang, C. H., Blethen, S. L., et al. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.8.7543110 · Cited by 121
Girnita, A., All‐Ericsson, C., Economou, M. A., Astr√∂m, K., Axelson, M., Seregard, S., Larsson, O., & Girnita, L. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1106 · Cited by 120
Treins, C., Giorgetti‐Peraldi, S., Murdaca, J., Monthouel, M.-N., & OBBERGHEN, E. V. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0239 · Cited by 120
Sachdev, D., Singh, R., Fujita‐Yamaguchi, Y., & Yee, D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3126 · Cited by 119
Boonen, S., Rosen, C. J., Bouillon, R., Sommer, A., McKay, M. J., Rosen, D. M., Adams, S., Broos, P. L. O., Lenaerts, J. L., Raus, J., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.4.8426 · Cited by 118
Miura, M., Surmacz, E., Burgaud, J., & Baserga, R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.38.22639 · Cited by 117
Backeljauw, P. F., & Underwood, L. E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.4.7381 · Cited by 116
Targeting insulin-like growth factor pathways
Yee, D. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602963 · Cited by 114
Wang, J., Niu, W., Witte, D. P., Chernausek, S. D., Nikiforov, Y. E., Clemens, T. L., Sharifi, B. G., Strauch, A. R., & Fagin, J. A. (1998) · Endocrinology · doi:10.1210/endo.139.5.5986 · Cited by 108
Bähr, M., Kolter, T., Seipke, G., & Eckel, J. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00903-x · Cited by 107
Häyry, P., Myllärniemi, M., Aavik, E., Alatalo, S., Aho, P., Yılmaz, S., Räisänen-Sokolowski, A. K., Cozzone, G., Jameson, B. A., & Baserga, R. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.13.7557024 · Cited by 101
Cosaceanu, D., Budiu, R. A., Carapancea, M., Castro, J., Lewensohn, R., & Dricu, A. (2006) · Oncogene · doi:10.1038/sj.onc.1210037 · Cited by 98
INSULIN-LIKE GROWTH FACTORS AND THEIR RECEPTORS IN GROWTH
D’Ercole, A. J. (1996) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70341-8 · Cited by 97
Insulin-like Growth Factor-I Receptor Signaling Blockade Combined with Radiation
Allen, G. W., Saba, C., Armstrong, E. A., Huang, S., Benavente, S., Ludwig, D. L., Hicklin, D. J., & Harari, P. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2000 · Cited by 94
Ye, P., Popken, G., Kemper, A., McCarthy, K. D., Popko, B., & D’Ercole, A. J. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20288 · Cited by 93
Mauras, N., & Beaufrère, B. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.3.7533772 · Cited by 90
Cardillo, M. R., Monti, S., Silverio, F. D., Gentile, V., Sciarra, F., & Toscano, V. (2003) · PubMed · Cited by 89
Thrailkill, K. M., Quattrin, T., Baker, L., Kuntze, J. E., Compton, P. G., & Martha, P. M. (1999) · Diabetes Care · doi:10.2337/diacare.22.4.585 · Cited by 88
The Insulin-like Growth Factor Axis in Cell Cycle Progression
Dupont, J., Pierre, A.-S., Froment, P., & Moreau, C. (2003) · Hormone and Metabolic Research · doi:10.1055/s-2004-814162 · Cited by 82
Zhu, B., Zhao, G., Witte, D. P., Hui, D. Y., & Fagin, J. A. (2001) · Endocrinology · doi:10.1210/endo.142.8.8331 · Cited by 81
Debroy, M. A., Wolf, S. E., Zhang, X., Chinkes, D. L., Ferrando, A. A., Wolfe, R. R., & Herndon, D. N. (1999) · doi:10.1097/00005373-199911000-00015 · Cited by 76
Cytokine inhibition of JAK-STAT signaling: a new mechanism of growth hormone resistance
Lang, C. H., Hong‐Brown, L. Q., & Frost, R. A. (2004) · Pediatric Nephrology · doi:10.1007/s00467-004-1607-9 · Cited by 76
Chen, C., Zhu, Y., Liu, X.-J., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010304b · Cited by 76
Tanno, B., Mancini, C., Vitali, R., Mancuso, M., McDowell, H. P., Dominici, C., & Raschellà, G. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1479 · Cited by 75
Clemmons, D. R., Moses, A. C., Sommer, A., Jacobson, W., Rogol, A. D., Sleevi, M., & Allan, G. (2005) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2005.05.002 · Cited by 74
Self-citationMotor neurone targeting of IGF‐1 prevents specific force decline in ageing mouse muscle
Payne, A. M., Zheng, Z., Messi, M. L., Milligan, C., Rodríguez, E. G., & Delbono, O. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.100032 · Cited by 72
Value of Insulin-like Growth Factor System Markers in the Assessment of Growth Hormone Status
Clemmons, D. R. (2007) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.11.008 · Cited by 70
Self-citationArnqvist, H. J., Bornfeldt, K., Chen, Y., & Lindström, T. (1995) · Metabolism · doi:10.1016/0026-0495(95)90222-8 · Cited by 69
Vlachopapadopoulou, E., Zachwieja, J., Gertner, J., Manzione, D., Bier, D. M., Matthews, D. E., & Slonim, A. (1995) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem.80.12.8530624 · Cited by 68
Endometrial Cancer and the IGF System: A Case-Control Study in Greece
Petridou, E. T., Koukoulomatis, P., Alexe, D. M., Voulgaris, Z., Spanos, E., & Trichopoulos, D. (2003) · Oncology · doi:10.1159/000070291 · Cited by 68
Gable, K., Maddux, B. A., Peñaranda, C., Zavodovskaya, M., Campbell, M. J., Lobo, M., Robinson, L., Schow, S. R., Kerner, J. A., Goldfine, I. D., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0397 · Cited by 68
Wu, K., Zhou, L., Burtrum, D. B., Ludwig, D. L., & Moore, M. A. S. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0196-9 · Cited by 65
Ling, Y., Maile, L. A., & Clemmons, D. R. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0143 · Cited by 64
Self-citationCatrina, S., Botusan, I. R., Rantanen, A., Catrina, A. I., Pyakurel, P., Savu, O., Axelson, M., Biberfeld, P., Poellinger, L., & Brismar, K. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2473 · Cited by 64
Samani, A. A., & Brodt, P. (2001) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(18)30066-8 · Cited by 64
Lee, H. K., Lee, J. H., Kim, M., Kariya, Y., Miyazaki, K., & Kim, E. K. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-0826 · Cited by 63
Miyamoto, S., Nakamura, M., Shitara, K., Nakamura, K., Ohki, Y., Ishii, G., Goya, M., Kodama, K., Sangai, T., Maeda, H., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1701 · Cited by 63
Yan, L., Maile, L. A., Lieskovská, J., Badley-Clarke, J., & Clemmons, D. R. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-10-0918 · Cited by 63
Self-citationInsulin-like growth factor-I treatment of growth disorders, diabetes mellitus and insulin resistance
Ranke, M. B. (2005) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2005.03.011 · Cited by 62
Saukkonen, T. T., Amin, R., Williams, R. M., Fox, C., Yuen, K. C. J., White, M. A., Umpleby, A. M., Acerini, C. L., & Dunger, D. B. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0243 · Cited by 62
MEYTS, P. D., Christoffersen, C. T., Ursø, B., Wallach, B. J., Grønskov, K., Yakushiji, F., & Shymko, R. M. (1995) · Metabolism · doi:10.1016/0026-0495(95)90214-7 · Cited by 59
Insulin‐like growth factor I receptors on mouse neuroblastoma cells
Ota, A., Wilson, G. L., & LeRoith, D. (1988) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1988.tb14130.x · Cited by 54
Shahrabani-Gargir, L., Pandita, T. K., & Werner, H. (2004) · Endocrinology · doi:10.1210/en.2004-0613 · Cited by 54
Pennisi, P., Gavrilova, O., Setser-Portas, J., Jou, W., Santopietro, S., Clemmons, D., Yakar, S., & LeRoith, D. (2006) · Endocrinology · doi:10.1210/en.2005-1556 · Cited by 51
Self-citationMini-proinsulin and mini-IGF-I: homologous protein sequences encoding non-homologous structures
Hua, Q. X., Hu, S.-Q., Jia, W., Chu, Y., Burke, G., Wang, S.-H., Wang, R.-Y., Katsoyannis, P. G., & Weiss, M. A. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1574 · Cited by 49
Increased Expression of Insulin-Like Growth Factor I is Associated with Ara-C Resistance in Leukemia
Abe, S., Funato, T., Takahashi, S., Yokoyama, H., Yamamoto, J., Tomiya, Y., Yamada‐Fujiwara, M., Ishizawa, K., Kameoka, J., Kaku, M., et al. (2006) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.209.217 · Cited by 46
Yi, H., Kim, S., Hwang, P., Kim, C. Y., Yang, D.-H., Oh, Y., & Lee, D. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.045 · Cited by 44
Liu, X.-J., Xie, Q., Zhu, Y., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100299200 · Cited by 42
Prawitt, D., Enklaar, T., Gärtner-Rupprecht, B., Spangenberg, C., Lausch, E. U., Reutzel, D., Fees, S. A., Korzon, M., Brożek, I., Limon, J., et al. (2005) · Nature Genetics · doi:10.1038/ng0805-785 · Cited by 41
Sakai, K., Lowman, H. B., & Clemmons, D. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107771200 · Cited by 36
Self-citationStawowy, P., Kallisch, H., Kilimnik, A., Margeta, C., Seidah, N. G., Chrétien, M., Fleck, E., & Graf, K. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.001 · Cited by 34
Roy, R. N., Gerulath, A., Cecutti, A., & Bhavnani, B. R. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00092-1 · Cited by 34
Hizuka, N., Fukuda, I., Takano, K., Asakawa‐Yasumoto, K., Okubo, Y., & Demura, H. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.8.5021 · Cited by 33
Differential regulation of signaling pathways for insulin and insulin-like growth factor I.
Lopaczyński, W. (1999) · Acta Biochimica Polonica · doi:10.18388/abp.1999_4183 · Cited by 32
Elliot, S. J., Karl, M., Berho, M. E., Xia, X., Pereria-Simon, S., Espinosa‐Heidmann, D. G., & Striker, G. E. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006070799 · Cited by 31
Swantek, J. L., & Baserga, R. (1999) · Endocrinology · doi:10.1210/endo.140.7.6766 · Cited by 28
LASSARRE, C., & Ricort, J. (2003) · Endocrinology · doi:10.1210/en.2002-0205 · Cited by 25
Quattrin, T., Thrailkill, K. M., Baker, L., Kuntze, J., Compton, P. G., Martha, P. O. A., & rhIGF-I in IDDM Study Group (2001) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2001.14.3.267 · Cited by 24
Kemp, S. F. (2007) · Drugs of today · doi:10.1358/dot.2007.43.3.1079876 · Cited by 19
The Insulin-Like Growth Factor I Generation Test in Adults
Lissett, C. A., Gleeson, H. K., & Shalet, S. M. (2004) · Hormone Research in Paediatrics · doi:10.1159/000080758 · Cited by 6
Cited by
Angiogenic signaling pathways and anti-angiogenic therapy for cancer
Liu, Z.-L., Chen, H.-H., Zheng, L.-L., Sun, L.-P., & Shi, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01460-1 · Cited by 1,300
Insulin resistance and cancer risk: An overview of the pathogenetic mechanisms
Arcidiacono, B., Iiritano, S., Nocera, A., Possidente, K., Nevolo, M. T., Ventura, V., Foti, D., Chiefari, E., & Brunetti, A. (2012) · Experimental Diabetes Research · doi:10.1155/2012/789174 · Cited by 606
The Role of Liver-Derived Insulin-Like Growth Factor-I
Ohlsson, C., Mohan, S., Sjögren, K., Tivesten, A., Isgaard, J., Isaksson, O., Jansson, J.-O., & Svensson, J. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0010 · Cited by 453
The Type 1 Insulin-Like Growth Factor Receptor Pathway
Chitnis, M. M., Yuen, J. S. P., Protheroe, A. S., Pollak, M., & Macaulay, V. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4879 · Cited by 445
Tumour-associated mutant p53 drives the Warburg effect
Zhang, C., Liu, J., Liang, Y., Wu, R., Zhao, Y., Hong, X., Lin, M., Yu, H., Liu, L., Levine, A. J., et al. (2013) · Nature Communications · doi:10.1038/ncomms3935 · Cited by 434
Metadata
- Authors
- Clemmons, D. R.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2007-10
- Volume
- 6
- Issue
- 10
- Pages
- 821-833
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2084361750
- Cited by
- 340
- References
- 149
- FWCI
- 2.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.